Dominus Investment

Dominus Investment is a Seoul-based private equity and growth capital investment firm, founded in 2011, operating as a domestic independent fund manager, with a focus on information technology and semiconductors investments across Korea.

Byoungwook Koh

Chief Investment Officer and Senior Partner, Private Equity

Chanwoo Lee

Chief Investment Officer and Managing Director

1 past transactions

Medytox

Seed Round in 2021
Medytox is a Korea-based biopharmaceutical company focused on the development, manufacture, and marketing of medical aesthetics and therapeutic products. Its primary offerings include type-A botulinum toxin, which is used to treat conditions such as blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis, and infantile cerebral palsy. Medytox markets its products under various brand names, including Neuronox and Siax. The company distributes its products both domestically and internationally, reaching markets in Japan, China, Russia, and Europe. In addition to its pharmaceutical products, Medytox is involved in providing information services related to public and financial aspects of its operations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.